These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 2475442

  • 21. Competition between tuftsin and HIV-1, HIV-2 envelope protein sequences.
    Siemion IZ, Słoń J, Wieczorek Z.
    Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):469-78. PubMed ID: 1841544
    [Abstract] [Full Text] [Related]

  • 22. Competition between tuftsin and HBV S-protein sequences.
    Siemion IZ, Słoń J, Nawrocka E, Wieczorek Z.
    Int J Pept Protein Res; 1990 May; 35(5):428-33. PubMed ID: 2376468
    [Abstract] [Full Text] [Related]

  • 23. Tuftsin (an Ig-associated tetrapeptide) triggers the immunogenic function of macrophages: implications for activation of programmed cells.
    Tzehoval E, Segal S, Stabinsky Y, Fridkin M, Spirer Z, Feldman M.
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3400-4. PubMed ID: 277940
    [Abstract] [Full Text] [Related]

  • 24. Influence of the peptide chain length of new elongated tuftsin analogs on phagocytosis process.
    Konopińska D, Kazanowska B, Bogusławska-Jaworska J.
    Int J Pept Protein Res; 1984 Sep; 24(3):267-73. PubMed ID: 6594319
    [Abstract] [Full Text] [Related]

  • 25. Synthesis and immunological evaluation of the conjugates composed from a muramyl peptide GMDP and tuftsin.
    Titov VM, Meshcheryakova EA, Balashova TA, Andronova TM, Ivanov VT.
    Int J Pept Protein Res; 1995 Apr; 45(4):348-55. PubMed ID: 7601608
    [Abstract] [Full Text] [Related]

  • 26. Do tuftsin and bestatin constitute a biopharmacological immunoregulatory system?
    Mathé G.
    Cancer Detect Prev Suppl; 1987 Apr; 1():445-55. PubMed ID: 3319151
    [Abstract] [Full Text] [Related]

  • 27. Biological and biochemical characteristics of the tetrapeptide tuftsin, Thr-Lys-Pro-Arg.
    Najjar VA.
    Adv Exp Med Biol; 1979 Apr; 121(A):131-47. PubMed ID: 398141
    [No Abstract] [Full Text] [Related]

  • 28. Antitumor effect of tuftsin.
    Nishioka K, Babcock GF, Phillips JH, Noyes RD.
    Mol Cell Biochem; 1981 Dec 04; 41():13-8. PubMed ID: 6895773
    [Abstract] [Full Text] [Related]

  • 29. Studies of human granulocyte phagocytosis stimulation by tuftsin.
    Nishioka K, Wagle JR, Rodriguez T, Maeta M, Kubo S, Dessens SE.
    J Surg Res; 1994 Jan 04; 56(1):94-101. PubMed ID: 8277776
    [Abstract] [Full Text] [Related]

  • 30. [Tuftsin--new analogues and properties].
    Wardowska A, Dzierzbicka K, Myśliwski A.
    Postepy Biochem; 2007 Jan 04; 53(1):60-5. PubMed ID: 17718389
    [Abstract] [Full Text] [Related]

  • 31. Enhanced phagocytosis activity of cyclic analogs of tuftsin.
    Nishioka K, Obeyesekere NU, McMurray JS.
    Biochem Pharmacol; 1995 Mar 01; 49(5):735-8. PubMed ID: 7887989
    [Abstract] [Full Text] [Related]

  • 32. The chemical synthesis of the phagocytosis-stimulating tetrapeptide tuftsin (Thr-Lys-Pro-Arg) and its biological properties.
    Nishioka K, Sato PS, Constantopoulos A, Najjar VA.
    Biochim Biophys Acta; 1973 May 17; 310(1):230-7. PubMed ID: 4710594
    [No Abstract] [Full Text] [Related]

  • 33. In vivo immunopharmacological properties of tuftsin (Thr-Lys-Pro-Arg) and some analogues.
    Florentin I, Chung V, Martinez J, Maral J, Le Garrec Y, Mathé G.
    Methods Find Exp Clin Pharmacol; 1986 Feb 17; 8(2):73-80. PubMed ID: 2423822
    [Abstract] [Full Text] [Related]

  • 34. New synthetic and natural tuftsin-related compounds and evaluation of their phagocytosis-stimulating activity.
    Martinez J, Winternitz F.
    Ann N Y Acad Sci; 1983 Feb 17; 419():23-34. PubMed ID: 6585171
    [Abstract] [Full Text] [Related]

  • 35. [Tuftsin].
    Mücke D.
    Allerg Immunol (Leipz); 1984 Feb 17; 30(3):127-38. PubMed ID: 6209973
    [Abstract] [Full Text] [Related]

  • 36. Antigen-tuftsin conjugate signals interleukin-1 synthesis and secretion.
    Dagan S, Tzehoval E, Tartakovsky B, Fridkin M, Feldman M.
    J Biol Response Mod; 1988 Dec 17; 7(6):546-58. PubMed ID: 3265146
    [Abstract] [Full Text] [Related]

  • 37. ADP-ribosylation of tuftsin suppresses its receptor-binding capacity and phagocytosis-stimulating activity to murine peritoneal macrophages.
    Terashima M, Hara N, Badruzzaman M, Shimoyama M, Tsuchiya M.
    FEBS Lett; 1997 Jul 21; 412(1):227-32. PubMed ID: 9257725
    [Abstract] [Full Text] [Related]

  • 38. The analgesic activity of some tuftsin- and tuftsin inhibitor-like fragments of the viral coat proteins.
    Obuchowicz E, Słoń JJ, Klin M, Madej A, Siemion IZ, Herman ZS.
    Pol J Pharmacol; 1993 Jul 21; 45(3):269-79. PubMed ID: 8220660
    [Abstract] [Full Text] [Related]

  • 39. Defective phagocytosis due to deficiencies involving the tetrapeptide tuftsin.
    Najjar VA.
    J Pediatr; 1975 Dec 21; 87(6 Pt 2):1121-4. PubMed ID: 1242395
    [Abstract] [Full Text] [Related]

  • 40. Tuftsin (Thr-Lys-Pro-Arg), a natural modulator of macrophage activity: further studies.
    Bump NJ, Najjar VA.
    Mol Cell Biochem; 1984 Sep 21; 63(2):137-42. PubMed ID: 6493218
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.